Researchers with the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have unveiled a critical ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...

Ozempic could help patients with advanced Alzheimer’s disease, scientists believe. Trials are underway examining the impact ...

Researchers have unveiled a critical mechanism that links cellular stress in the brain to the progression of Alzheimer's disease (AD). The study highlights microglia, the brain's primary immune cells, ...

It’s a renewal of an earlier grant this year. The total funding now amounts to $860,000 and aims to cover six years of ...

A new study by researchers at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) has unveiled how ...

Discover how stressed-out immune cells in the brain may be the key culprit behind the development of Alzheimer's disease.

It should come as no surprise that Alzheimer’s has touched the lives of two individuals designated by President-elect Donald ...

Early research links the human cytomegalovirus, a type of herpes virus found in the gut, to the development of Alzheimer’s ...

Even as new drugs come to market, further study appears to point to infections as a possible cause for the debilitating ...

"Such treatments could significantly slow or even reverse the progression of Alzheimer's disease, offering hope to millions of patients and their families," explained co-lead author Leen Aljayousi ...

Researchers say the breakthrough marks a "promising" target for drug treatments that slow, or possibly even reverse, the ...